A more recent study on human IH revealed that propranolol, the first Food and Drug Administration (FDA)-approved drug for the treatment of the tumor, inhibits the growth of hemangioma endothelial cells partly by inhibiting VEGF secretion [21]. The gene discussed is VEGFA; the disease is hemangioma.